Conferences

Catalog

Abstracts

Calendar

Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026

Name: Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026
Start: 2026-02-27T08:00:00+00:00
End: 2026-02-28T08:00:00+00:00
Location: Sonesta Redondo Beach & Marina

Accreditation: 10.50 Nursing Contact Hours | 10.50 ACPE Pharmacy | 10.50 ABIM MOC II | 10.50 AMA PRA Category 1 Credit™

Venue: Sonesta Redondo Beach & Marina, 300 North Harbor Drive, Redondo Beach, CA, United States

Start Date: February 27End Date: February 28, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

56+

Email if you have questions[email protected]

Our Speakers

Planning Committee

Justin Ryan Marquart, MBA

Conference Chair

Binaytara

Faculty

Thomas Martin, MD

Session Chair

Binaytara

Matthew Mei, MD

Session Chair

Binaytara

Murali Janakiram, MD

Session Chair

Binaytara

Vinod Pullarkat, MD

Session Chair

Binaytara

Michael Rosenzweig, MD

Session Chair

Binaytara

Brian A Jonas

Session Chair

Binaytara

Jerald Radich, MD

Session Chair

Binaytara

Anupama Deepa Kumar, MD

Session Chair

Binaytara

Brian Sworder, MD, MD, PhD, PhD

Session Chair

Binaytara

Jonathan L Kaufman, MD

Session Chair

Binaytara

Victor Manuel Orellana-Noia, MD

Faculty

Binaytara

Lihong Wu, MD

Faculty

Binaytara

Harsh Shah, DO

Faculty

Binaytara

Robert Matthew Carroll, MD

Faculty

Binaytara

Matthew J. Cortese, MD, MPH

Faculty

Binaytara

Joseph Patrick Marshalek, MD, MD

Faculty

Binaytara

Ryotaro Nakamura, MD

Faculty

Binaytara

Idoroenyi Amanam, MD

Faculty

Binaytara

Kwan-Keat Ang, MD, MD

Faculty

Binaytara

Amanda Blackmon, DO

Faculty

Binaytara

Saro Kasparian

Faculty

Binaytara

Holly Lee, MD

Faculty

Binaytara

Wanxing Chai-Ho, MD

Faculty

Binaytara

Claire Carlson, PharmD

Faculty

Binaytara

Diana Tran Samuels, PharmD, PharmD

Faculty

Binaytara

Aaron S Rosenberg, MD

Faculty

Binaytara

Hun Ju Lee, MD

Faculty

Binaytara

Sarah S Lee, MD, MD

Faculty

Binaytara

Maria Motta, ARNP, DNP

Faculty

Binaytara

Cynthia Fu, PharmD

Faculty

Binaytara

J Christine Ye, MD

Faculty

Binaytara

Angela Fleischman, MD, MD, PhD

Faculty

Binaytara

Gabriel Park, PharmD

Faculty

Binaytara

Tamer Othman, MD

Faculty

Binaytara

Brian V Lee

Faculty

Binaytara

Jodi Lipof, MD

Faculty

Binaytara

Kwan-Keat Ang

Faculty

Binaytara

Our Agenda

Day 1: Friday, February 27th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

12:30 PM - 01:30 PMRegistration, Networking, & Exhibits (Seascape Room)

01:30 PM - 02:00 PMSession 1: Plenary Lecture (Peninsula Room)

01:30 PM - 01:50 PM

Plenary Lecture – Brian Sworder, MD, MD, PhD, PhD

01:50 PM - 02:00 PM

Q&A

02:00 PM - 03:15 PMSession 2: Lymphoma (Peninsula Room)

Session Chair: Matthew Mei, MD

02:00 PM - 02:15 PM

CLL - How to approach cases refractory to both a covalent BTKi and a BCL2 Inhibitor – Matthew J. Cortese, MD, MPH

02:15 PM - 02:30 PM

Have we solved HL? What are the unmet needs in 2025? – Harsh Shah, DO

02:30 PM - 02:45 PM

Update in R/R MZL – Matthew Mei, MD

02:45 PM - 03:15 PM

Case-Based Panel Discussion – Lihong Wu, MD

03:15 PM - 03:45 PMBreak & Exhibits (Seascape Room)

03:45 PM - 05:15 PMSession 3: Leukemia (Peninsula Room)

Session Chair: Vinod Pullarkat, MD; Brian A Jonas

03:45 PM - 04:00 PM

Induction for acute myeloid leukemia: Does anyone still need 7+ 3 ? – Brian A Jonas

04:00 PM - 04:15 PM

Adding targeted agents to AML therapy backbone – Amanda Blackmon, DO

04:15 PM - 04:30 PM

Chemotherapy or chemotherapy free : Treatment of Philadelphia positive ALL – Tamer Othman, MD

04:30 PM - 04:45 PM

Who needs transplant for ALL in CR1 : Genetics vs MRD – Vinod Pullarkat, MD

04:45 PM - 05:15 PM

Case-Based Panel Discussion – Robert Matthew Carroll, MD

Day 2: Saturday, February 28th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits (Seascape Room)

08:00 AM - 08:15 AMBinaytara's Efforts in Improving Cancer Care Disparities (Peninsula Room)

Conference Chair: Justin Ryan Marquart, MBA

08:15 AM - 09:45 AMSession 4: Optimizing Frontline Treatment Multiple Myeloma (Peninsula Room)

Session Chair: Jonathan L Kaufman, MD; Michael Rosenzweig, MD

08:15 AM - 08:30 AM

Newly Diagnosed TI - Optimal Treatment in 2026 – Which regimen and for how long ? – Michael Rosenzweig, MD

08:30 AM - 08:50 AM

Debate: Frontline TE in MM

08:30 AM - 08:40 AM

MRD stands for Make the Right Decision on Transplant – Aaron S Rosenberg, MD

08:40 AM - 08:50 AM

MRD stands for DON’T Make the wRong Decision regarding Upfront Transplant – Jodi Lipof, MD

08:50 AM - 09:05 AM

Optimal Maintenance - Which agents for SR/HR - MRD Guided? – Jonathan L Kaufman, MD

09:05 AM - 09:20 AM

Evaluation and Treatment of the Frail Patient – J Christine Ye, MD

09:20 AM - 09:35 AM

Triplets and ADCs – When and How to Sequence in RRMM – Sarah S Lee, MD, MD

09:35 AM - 09:45 AM

Case Presentation – Kwan-Keat Ang, MD, MD

09:45 AM - 10:15 AMBreak & Exhibits (Seascape Room)

10:15 AM - 11:45 AMSession 5: Leukemia II (Peninsula Room)

Session Chair: Vinod Pullarkat, MD; Jerald Radich, MD

10:15 AM - 10:30 AM

Prognostication of MDS and timing of stem cell transplant – Wanxing Chai-Ho, MD

10:30 AM - 10:45 AM

MRD monitoring in AML. How and when? – Jerald Radich, MD

10:45 AM - 11:00 AM

Treatment of aplastic anemia in adults: Choosing IST vs transplant – Ryotaro Nakamura, MD

11:00 AM - 11:15 AM

MPN: Do available drugs provide survival benefit? – Angela Fleischman, MD, MD, PhD

11:15 AM - 11:45 AM

Case-Based Panel Discussion – Idoroenyi Amanam, MD; Saro Kasparian

11:45 AM - 12:30 PMSession 6: Pharmacist & APP Session: Monitoring and managing side effects of targeted agents for AML (Peninsula Room)

11:45 AM - 11:55 AM

IDH Inhibitors – Diana Tran Samuels, PharmD, PharmD

11:55 AM - 12:05 PM

Menin Inhibitors – Maria Motta, DNP, ARNP

12:05 PM - 12:15 PM

FLT3 Inhibitors – Gabriel Park, PharmD

12:15 PM - 12:30 PM

Case-Based Panel Discussion – Maria Motta, DNP, ARNP; Gabriel Park, PharmD; Diana Tran Samuels, PharmD, PharmD

12:30 PM - 01:30 PMLunch & Exhibits (Seascape Room)

About Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026

Overview

Faculty and committee

Our Speakers

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Our Agenda